Your browser doesn't support javascript.
loading
Regarding γ' fibrinogen levels as a biomarker of COVID-19 respiratory disease severity.
Kornblith, Lucy Z; Sadhanandhan, Bindhya; Arun, Sreepriya; Long, Rebecca; Johnson, Alicia J; Noll, Jamie; Ramchand, C N; Olynyk, John K; Farrell, David H.
Afiliação
  • Kornblith LZ; Department of Surgery, University of California, San Francisco, CA, USA.
  • Sadhanandhan B; Theragen Biologics Pvt Ltd, Chennai, India.
  • Arun S; Theragen Biologics Pvt Ltd, Chennai, India.
  • Long R; Fiona Stanley Fremantle Hospital Group, Murdoch, Western Australia, Australia; Edith Cowan University, Joondalup, Western Australia, Australia.
  • Johnson AJ; Department of Surgery, Oregon Health & Science University, Portland, OR, USA.
  • Noll J; Gamma Diagnostics, Portland, OR, USA.
  • Ramchand CN; MagGenome Pvt Ltd, Chennai, India.
  • Olynyk JK; Fiona Stanley Fremantle Hospital Group, Murdoch, Western Australia, Australia; Edith Cowan University, Joondalup, Western Australia, Australia.
  • Farrell DH; Department of Surgery, Oregon Health & Science University, Portland, OR, USA. Electronic address: farrelld@ohsu.edu.
Blood Cells Mol Dis ; 105: 102825, 2024 03.
Article em En | MEDLINE | ID: mdl-38278055
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibrinogênio / COVID-19 Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibrinogênio / COVID-19 Idioma: En Ano de publicação: 2024 Tipo de documento: Article